Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01440205 · ClinicalTrials.gov registry record · NA
Licensing Flu Shot Study
A NA study, sponsored by University of Pennsylvania.
- Completed
- Registry status
- NA
- Development phase
- 6,098
- Enrollment target
NCT01440205: Completed NA study, sponsored by University of Pennsylvania.
NCT01440205 is a NA study that has completed, run by University of Pennsylvania. The registered enrollment target is 6,098 participants, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (335% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01440205, a NA study, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- NA
- Development phase
- 6,098 participants
- Enrollment target
Study Summary
The mailer will encourage all employees of one of Evive's partner companies to attend an on-site free flu shot clinic they are offering in the fall of 2011. The research will examine differences in follow-through on getting a flu shot at an on-site clinic among the targeted population during the \~1 month period when clinics are being offered (following the mailing) as a function of experimental condition.
Interventions
- BEHAVIORAL Control
- BEHAVIORAL Easy list of healthy habits
- BEHAVIORAL Challenging list of healthy habits
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6,098 participants |
| Start Date | 2011-09 |
| Est. Completion | 2012-05 |
| Phase | NA |
What the finished NCT01440205 record still lists
NCT01440205 is an interventional study that assigns participants to a tested intervention. Its 6,098 participants enrollment target places it among the larger protocols in the corpus, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (335% higher).
The record links to 0 conditions, and to 3 interventions - of which Control is the first listed.
NCT01440205 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01440205 about?
NCT01440205 is a clinical study titled "Licensing Flu Shot Study". The mailer will encourage all employees of one of Evive's partner companies to attend an on-site free flu shot clinic they are offering in the fall of 2011. The research will examine differences in follow-through on getting a flu shot at an on-site clinic among the targeted population during the \~1...
What is the current status of trial NCT01440205?
This trial is currently completed. It is a NA study. The enrollment target is 6,098 participants. The study started on 2011-09. Estimated completion is 2012-05.
What interventions are being tested in trial NCT01440205?
The interventions under investigation include: Control (BEHAVIORAL), Easy list of healthy habits (BEHAVIORAL), Challenging list of healthy habits (BEHAVIORAL).
Who is sponsoring clinical trial NCT01440205?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01440205's enrollment target sits among peer trials
6,098 22nd of 2000 higher than 1,979 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07166861 · 6,080 participants · NA
Annual Wellness Visits vs GRACE-augmented Annual Wellness Visits For Older Adults With High Needs - Phase 2
- NCT04774159 · 6,150 participants · Phase 3
Low Dose ColchicinE in pAtients With Peripheral Artery DiseasE to Address Residual Vascular Risk
- NCT06304168 · 6,150 participants
Validation of DNA Methylation Markers for Universal and Site-specific Guided Cancer Detection, VANGUARD Study
- NCT05884190 · 6,030 participants · NA
Trauma-informed Approach to Timely Detection and Management of Early Postpartum Hypertension
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia